<DOC>
	<DOCNO>NCT00222638</DOCNO>
	<brief_summary>The purpose study evaluate INR INR relate index Warfarin weekly dosage variation Influenza Vaccination</brief_summary>
	<brief_title>Influenza Vaccination Oral Anticoagulant Therapy</brief_title>
	<detailed_description>The pharmacokinetic pharmacodynamic interaction possible clinical event connect simultaneous administration Oral Anticoagulants ( OA ) influenza virus vaccine evaluate several small study yield conflict result , thus encouraging additional investigation prospective study order obtain consistent evidence safety efficacy vaccination influenza virus patient OA Treatment .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>OA Treatment Stable anticoagulation ( previous two control range ) Presence indication Influenza Vaccination Life expectancy &gt; 6 month Signed Informed consent Absence stable anticoagulation Absence indication Influenza Vaccination Life expectancy &lt; 6 month Denied Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2005</verification_date>
	<keyword>Oral anticoagulant</keyword>
	<keyword>Influenza virus</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Pharmacological interference</keyword>
</DOC>